Chris Stevo | Senior Vice President and Chief Investor Relations Officer |
Albert Bourla | Chairman and Chief Executive Officer |
Frank D’amelio | Chief Financial Officer |
Mikael Dolsten | President of Worldwide Research and Development in Medical |
Angela Hwang | Group President Pfizer Biopharmaceuticals Group |
Aamir Malik | Chief Business Innovation Officer |
Doug Lankler | General Counsel |
Umer Raffat | Evercore |
Vamil Divan | Mizuho Securities |
Tim Anderson | Wolfe Research |
Ronny Gal | Bernstein |
Steve Scala | Cowen |
Louise Chen | Cantor |
Matthew Harrison | Morgan Stanley |
Chris Schott | JPMorgan |
Geoffrey Porges | FVB |
Andrew Baum | Citi |
Carter Gould | Barclays |
Good day, everyone, and welcome to Pfizer's Third Quarter 2021 Earnings Conference Call. Today's call is being recorded. At this time, I would like to turn the call over to Mr. Chris Stevo, Senior Vice President and Chief Investor Relations Officer. Please go ahead, sir.